However, in synergy with TBC1D5 overexpression, rapamycin inhibits ccRCC migration and lipid droplet reduction (Fig. 4G and Additional file 5: Fig. S5B). The gene discussed is TBC1D5; the disease is nonpapillary renal cell carcinoma.